LSV Asset Management Sells 19,700 Shares of Phibro Animal Health Corporation $PAHC

LSV Asset Management lowered its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 8.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 203,700 shares of the company’s stock after selling 19,700 shares during the quarter. LSV Asset Management owned 0.50% of Phibro Animal Health worth $8,242,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC lifted its stake in Phibro Animal Health by 7,671.4% during the second quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after purchasing an additional 2,685 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of Phibro Animal Health by 768.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock valued at $118,000 after buying an additional 4,079 shares in the last quarter. State of Wyoming lifted its position in Phibro Animal Health by 148.8% in the 2nd quarter. State of Wyoming now owns 6,608 shares of the company’s stock worth $169,000 after buying an additional 3,952 shares during the last quarter. Yousif Capital Management LLC purchased a new stake in Phibro Animal Health in the second quarter worth approximately $200,000. Finally, Arizona State Retirement System purchased a new stake in Phibro Animal Health in the third quarter worth approximately $243,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Phibro Animal Health

In related news, CEO Jack Bendheim sold 14,184 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $51.62, for a total value of $732,178.08. Following the completion of the transaction, the chief executive officer directly owned 50,760 shares of the company’s stock, valued at $2,620,231.20. This represents a 21.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Over the last 90 days, insiders have sold 279,840 shares of company stock worth $13,105,371. Insiders own 50.13% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on PAHC shares. Morgan Stanley set a $49.00 price target on shares of Phibro Animal Health in a research note on Friday, February 6th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Monday, December 29th. JPMorgan Chase & Co. upped their price target on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. Finally, Zacks Research cut Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 9th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $37.50.

Phibro Animal Health Trading Up 2.0%

PAHC opened at $52.26 on Monday. Phibro Animal Health Corporation has a one year low of $16.16 and a one year high of $56.30. The company has a debt-to-equity ratio of 2.14, a current ratio of 3.05 and a quick ratio of 1.22. The business has a 50 day simple moving average of $41.22 and a two-hundred day simple moving average of $39.25. The firm has a market capitalization of $2.12 billion, a price-to-earnings ratio of 23.23, a PEG ratio of 0.80 and a beta of 0.80.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, February 4th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.18. Phibro Animal Health had a return on equity of 38.28% and a net margin of 6.29%.The firm had revenue of $373.91 million for the quarter, compared to analysts’ expectations of $355.64 million. Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. Analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Wednesday, March 4th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, March 4th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 21.33%.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.